Samir Parekh, MD, Appointed Director of the Center of Excellence for Multiple Myeloma at Mount Sinai

Samir Parekh, MD, has been named Director of the Center of Excellence for Multiple Myeloma at The Tisch Cancer Institute at the Icahn School of Medicine at Mount Sinai in New York, New York.

Dr. Parekh’s laboratory focuses on developing personalized treatment strategies for patients with multiple myeloma using genomics and immunology.

“It’s a very humbling position, and I’m honored to be chosen to lead a very talented group of physicians and scientists at Mount Sinai, as well as a large team of nurse practitioners, nurses, and researchers that do clinical research,” Dr. Parekh told Blood Cancers Today. “The team was set up by Sundar Jagannath, MBBS, and has been growing since. We have about 150 people who help support myeloma patients, including social workers and ancillary staff.”

Mount Sinai operates 3 sites in New York City for treating patients and conducting clinical research: the Upper East Side, Chelsea, and Brooklyn. In the future, the hospital will expand its practice to New Jersey and Long Island, Dr. Parekh said.

“I’m happy to be helping lead this program, and I’m happy that the lab I lead has been publishing and finding new things that can help patients directly, whether it’s making observations about CAR-T [chimeric antigen receptor T-cell] resistance and bispecific resistance or coming up with new therapeutic options when patients face challenging situations in the clinic,” he concluded.

Reference

Mount Sinai names Samir Parekh, MD, as director of the Center of Excellence for Multiple Myeloma. Mount Sinai. News release. Published March 26, 2025. Accessed April 11, 2025. https://www.mountsinai.org/about/newsroom/2025/mount-sinai-names-samir-parekh-md-as-director-of-the-center-of-excellence-for-multiple-myeloma